Related Experiment Videos
SF3B1 and BAP1 mutations in blue nevus-like melanoma
Klaus G Griewank1,2, Hansgeorg Müller3, Louise A Jackett4,5,6
1Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Summary
Genetic analysis of blue nevi reveals specific mutations, like BAP1 and SF3B1, that can help diagnose aggressive blue nevus-like melanoma. This finding aids in distinguishing these tumors from conventional melanomas.
Area of Science:
- Dermatopathology
- Oncology
- Cancer Genetics
Background:
- Blue nevi are dermal melanocytic tumors with potential for malignant transformation.
- Distinguishing aggressive blue nevus-like melanoma from benign blue nevi is clinically challenging.
- Genetic similarities exist between blue nevi and uveal melanomas, including GNAQ/GNA11 mutations.
Purpose of the Study:
- To investigate genetic alterations in blue nevi and related tumors.
- To identify genetic markers that can aid in the diagnosis and prognostication of blue nevus-like melanoma.
- To compare the genetic profiles of blue nevi, blue nevus-like melanoma, and conventional melanomas.
Main Methods:
- Analysis of a cohort of 301 blue nevi and related tumors.
- Screening for gene mutations known in uveal melanoma, including GNAQ, GNA11, CYSLTR2, PLCB4, EIF1AX, SF3B1, and BAP1.
- Sequencing of a larger cohort of cutaneous melanomas to identify similar genetic profiles.
Main Results:
- Most blue nevi harbored GNAQ (53%) or GNA11 (15%) mutations.
- Rare CYSLTR2 and PLCB4 mutations were identified.
- BAP1 and SF3B1 R625 mutations were exclusively found in malignant tumors, specifically blue nevus-like melanoma.
- The genetic profile of GNAQ/GNA11 with BAP1/SF3B1 mutations was also found in some cutaneous melanomas not initially diagnosed as blue nevus-like.
Conclusions:
- Coexistent GNAQ/GNA11 and BAP1/SF3B1 mutations can assist in diagnosing blue nevus-like melanoma.
- This genetic profile helps differentiate blue nevus-like melanoma from conventional epidermal melanomas.
- Further research is needed to understand the prognostic implications and clinical management of these specific mutation profiles.